TimesSquare Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
TimesSquare Capital Management's RGEN Position: Q2 2026 in Review
TimesSquare Capital Management reduced its Repligen (RGEN) stake by 2% in Q2 2026, selling an estimated $1.12M and leaving 446,964 shares worth $61M. The position accounts for 0.9% of the portfolio, ranked #37.
TimesSquare Capital Management first reported a position in RGEN in Q3 2016 and has held it in 23 quarters since. The position peaked at $97.9M in Q2 2017. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- TimesSquare Capital Management held 446,964 shares of Repligen worth $61M as of Q2 2026.
- TimesSquare Capital Management sold 9,119 Repligen shares in Q2 2026, an estimated $1.12M.
- Repligen made up 0.9% of TimesSquare Capital Management's portfolio in Q2 2026, its #37 holding.
- TimesSquare Capital Management first reported a position in Repligen in Q3 2016 and has held it in 23 quarters since.
- TimesSquare Capital Management's Repligen position peaked at $97.9M in Q2 2017.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on TimesSquare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.